http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106986895-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e74277852f1aae0a3ff13f59a65456d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65842 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6584 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2017-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0817a83409373a0fb2c105ab6b416e42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ff75271ea7123a48b261cbc40772515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6df8551117eae6704e6b3220095632a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a973e26593dcf94cd75ede3bfc51a3da |
| publicationDate | 2017-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106986895-A |
| titleOfInvention | Quinazoline multi-target anti-tumor compound and its preparation method and application |
| abstract | The present invention provides a kind of quinazoline class multi-target anti-tumor compound as shown in chemical formula (I) and preparation method thereof, especially relate to EGFR, HER-2 and DNA multi-target anti-tumor compound, also provide its preparation method and Application in antitumor drugs. Studies have shown that the compound of the present invention has significant antitumor activity, and its metabolic stability has been significantly improved compared with the reference substance EMB-3. |
| priorityDate | 2017-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.